Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder

Clinical trial NCT01255787 · COMPLETED

Trial details

NCT number: NCT01255787
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2010-11-01
Primary completion: 2012-03-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.